Sadeghi K, et al. - Researchers here focused on the high-dose amikacin for achieving serum target levels in critically ill elderly patients. As per findings, researchers recommended determining the optimum dose of amikacin for these patients. Compared to standard once-daily dosing, higher-than-standard doses of amikacin with more extended intervals could be more appropriate in the elderly critically ill patients.